Moderna
Dr. Ted Liska is a Senior Scientist at Moderna who investigates the assembly of LNPs and their surface properties. He holds a PhD in Chemistry from Case Western Reserve University, specializing in organometallic synthesis and computational modeling. In his professional work, he has contributed to nanoscale formulation engineering and delivery science, holding a patent on nanocrystalline formulations, and helping bring two nanoparticle-based drugs to market. At Moderna, Dr. Liska is at the forefront of integrating virtual and physical components to build automated, AI-partnered, closed-loop execution systems for research and manufacturing of mRNA-LNPs. His work emphasizes the creation of new Human-Computer Interfaces that leverage emerging technologies to serve as dynamic, virtual complements to physical lab processes and human scientific curiosity.
Disclosure information not submitted.
Monday, February 5, 2024
2:00 PM – 3:00 PM EST